Page last updated: 2024-11-03

ag 1879 and Alzheimer Disease

ag 1879 has been researched along with Alzheimer Disease in 1 studies

3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, RJ1
Chang, WW1
Lin, YC1
Cheng, PL1
Chen, YR1

Other Studies

1 other study available for ag 1879 and Alzheimer Disease

ArticleYear
Alzheimer's amyloid-β oligomers rescue cellular prion protein induced tau reduction via the Fyn pathway.
    ACS chemical neuroscience, 2013, Sep-18, Volume: 4, Issue:9

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Butadienes; Cell Line, Tumor; Down-Regulation; Hu

2013